|
Dec 31
|
Capital Allocation Trends At Penumbra (NYSE:PEN) Aren't Ideal
|
|
Dec 30
|
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Dec 23
|
Here's Why Penumbra (PEN) is a Strong Growth Stock
|
|
Dec 20
|
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
|
|
Dec 19
|
Penumbra price target raised to $285 from $240 at Truist
|